Joshua Fein, MD, is a hematologist and medical oncologist with advanced expertise in bone marrow and stem cell transplantation and cellular therapy. He is an Assistant Professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine and an Assistant Attending Physician at NewYork-Presbyterian Hospital. Clinically, Dr. Fein focuses on autologous and allogeneic transplantation, CAR-T and other cellular therapies, and comprehensive care for patients with complex blood and marrow conditions. His research interests center on immune system recovery after donor stem cell transplantation, biomarker- and data-driven personalization of transplant care, and improving safety through informatics and the prevention and management of cellular therapy–related toxicities. He serves as Chair of Quality Assurance and Director of Informatics for the Bone Marrow Transplant and Cellular Therapy Program at Weill Cornell, and his work has been recognized with the KL2 Clinical Scholar Award, the American Society of Hematology Research Training Award for Fellows, and Weill Cornell’s Cheers for Peers Recognition. Dr. Fein earned his MD from the Sackler School of Medicine (American Program), Tel Aviv University, completed residency in Internal Medicine at UConn Health, and completed fellowship training in Hematology and Medical Oncology at Weill Cornell Medicine/NewYork-Presbyterian Hospital.
Assistant Professor
Medical School
2015 – 2019
Residency
2019 – 2022
Fellowship
2022 – 2025